ClinicalTrials.gov
public full text
Public Domain
Docosahexaenoic Acid (DHA) Supplementation in Amblyopia
This study evaluates the addition of docosahexaenoic acid (DHA) to eye patching in the treatment of residual amblyopia in children ages 3 to 18 years old. Two thirds of participants will receive DHA along with eye patching, while one third of participants will receive a placebo along with eye patching.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Over-glasses Patch Treatment for Amblyopia in Children : OPTA Study#1009803
- Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old#917813
- Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia#888285
- Monocular Action Video Game Treatment of Amblyopia#830546
- Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses#870471
Record · ID 1044272
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive